Cardiorentis AG
http://www.cardiorentis.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Cardiorentis AG
Pipeline Watch: Phase III Progress With Erenumab, Sirukumab And Sarilumab
Pipeline Watch has been updated to bring greater depth and detail to a potential therapeutic product’s progress through the R&D pipeline. The table brings you a snapshot of selected late-stage clinical trial events in the pharma and biotech industries.
Start-Up Execs On The Move, February 2016
Recent executive-level hires and director appointments at venture capital firms and biopharma and medtech start-ups.
Execs On The Move, February 2016
Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
Venture Funding Deals, February 2016
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging life science companies that have received venture funding, including companies within the In Vitro Diagnostics, Medical Devices, Pharmaceuticals, and Research, Analytical Equipment and Supplies sectors. This month’s column covers deals announced December 2015 through January 2016.
Company Information
- Industry
- Miscellaneous
-
Biotechnology
-
Drug Discovery Tools
-
Molecular Diversity
- Natural Products
-
Molecular Diversity
-
Drug Discovery Tools
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice